Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skeletal Muscle Wasting in SARS-CoV-2 Infected ICU (Intensive Care Unit) Patients

NCT04698798 is registered in ClinicalTrials.gov with Hasselt University as lead sponsor.

NCT NCT04698798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skeletal Muscle Wasting in SARS-CoV-2 Infected ICU (Intensive Care Unit) Patients
Lead sponsor
Hasselt University
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2021
Completion date
April 3, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, critical illness, muscle atrophy, muscle loss, muscle wasting